Cetraxate

Cetraxate is an orally active antiulcer Drug. Cetraxate increases the blood flow of gastric mucosal. Cetraxate increases the eradication of Helicobacter pylori in smokers when in combination with Omeprazole (HY-B0113), Amoxicillin (HY-B0467A), and Clarithromycin (HY-17508) [1].

Product Specifications

CAS Number

[34675-84-8]

UNSPSC

12352005

Hazard Statement

H301-H311-H331

Target

Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/cetraxate.html

Solubility

10 mM in DMSO

Smiles

OC(CCC(C=C1)=CC=C1OC([C@H]2CC[C@@H](CC2)CN)=O)=O

Molecular Formula

C17H23NO4

Molecular Weight

305.37

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P361+P364-P405-P501

References & Citations

[1]Kamada T, et al. Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers. Aliment Pharmacol Ther. 2000 Aug;14 (8) :1089-94.